{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:01:46Z","timestamp":1779937306778,"version":"3.53.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01715-9","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:55:35Z","timestamp":1776441335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuro-Behavioral Improvement and Mechanistic Pathways of Bone Marrow-Derived Mesenchymal Stem Cells and Exosomes in Experimental Multiple Sclerosis: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Hadis","family":"Kariminejad-Farsangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniyeh","family":"Kariminejad-Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Azh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ghadery Nasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzie","family":"Dehghan-Kuroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Joushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1715_CR84","doi-asserted-by":"publisher","unstructured":"Abramowski P, Krasemann S, Ernst T, Lange C, Ittrich H, Schweizer M, Fehse B (2016) Mesenchymal stromal\/stem cells do not ameliorate experimental autoimmune encephalomyelitis and are not detectable in the central nervous system of transplanted mice. Stem Cells Dev 25(15):1134-1148. https:\/\/doi.org\/10.1089\/scd.2016.0020","DOI":"10.1089\/scd.2016.0020"},{"issue":"1","key":"1715_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13287-022-03219-x","volume":"14","author":"W Akhter","year":"2023","unstructured":"Akhter W, Nakhle J, Vaillant L, Garcin G, Le Saout C, Simon M et al (2023) Transfer of mesenchymal stem cell mitochondria to CD4 + T cells contributes to repress Th1 differentiation by downregulating T-bet expression. Stem Cell Res Ther 14(1):12. https:\/\/doi.org\/10.1186\/s13287-022-03219-x","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"1715_CR2","doi-asserted-by":"publisher","first-page":"9298","DOI":"10.3390\/ijms13079298","volume":"13","author":"MA Al Jumah","year":"2012","unstructured":"Al Jumah MA, Abumaree MH (2012) The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS). Int J Mol Sci 13(7):9298\u20139331","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1715_CR3","doi-asserted-by":"publisher","first-page":"20f13681","DOI":"10.4088\/JCP.20f13681","volume":"81","author":"C Andrade","year":"2020","unstructured":"Andrade C (2020) Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry 81(5):20f13681","journal-title":"J Clin Psychiatry"},{"key":"1715_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","volume":"6","author":"G Arellano","year":"2015","unstructured":"Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R (2015) Stage-specific role of interferon-Gamma in experimental autoimmune encephalomyelitis and multiple sclerosis. Front Immunol 6:492","journal-title":"Front Immunol"},{"issue":"2","key":"1715_CR5","first-page":"389","volume":"12","author":"H Baharlooi","year":"2022","unstructured":"Baharlooi H, Salehi Z, Minbashi Moeini M, Rezaei N, Azimi M (2022) Immunomodulatory potential of human mesenchymal stem cells and their exosomes on multiple sclerosis. Adv Pharm Bull 12(2):389\u2013397","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"1715_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02146-0","volume":"24","author":"A Bannach-Brown","year":"2024","unstructured":"Bannach-Brown A, Rackoll T, Kaynak N, Drude N, Aquarius R, Vojvodi\u0107 S et al (2024) Navigating PROSPERO4animals: 10 top tips for efficient pre-registration of your animal systematic review protocol. BMC Med Res Methodol 24(1):20","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"1715_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00401-019-01980-7","volume":"137","author":"R Brambilla","year":"2019","unstructured":"Brambilla R (2019) The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neuropathol 137(5):757\u2013783","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1715_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3727\/096368912X657404","volume":"22","author":"M Cobo","year":"2013","unstructured":"Cobo M, Anderson P, Benabdellah K, Toscano MG, Mu\u00f1oz P, Garc\u00eda-P\u00e9rez A et al (2013) Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis. Cell Transpl 22(5):839\u2013854","journal-title":"Cell Transpl"},{"issue":"7","key":"1715_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.4161\/auto.28771","volume":"10","author":"S Dang","year":"2014","unstructured":"Dang S, Xu H, Xu C, Cai W, Li Q, Cheng Y et al (2014) Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis. Autophagy 10(7):1301\u20131315","journal-title":"Autophagy"},{"issue":"9","key":"1715_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15(9):545\u2013558","journal-title":"Nat Rev Immunol"},{"key":"1715_CR83","doi-asserted-by":"publisher","unstructured":"DingYuan Oh, Peng Cui, Hamid Hosseini, Jennifer Mosse, Ban-Hock Toh, James Chan, Potently Immunosuppressive 5-Fluorouracil\u2013Resistant Mesenchymal Stromal Cells Completely Remit an Experimental Autoimmune Disease, J Immuno. Volume 188, Issue 5, March 2012, Pages 2207\u20132217 https:\/\/doi.org\/10.4049\/jimmunol.1101040","DOI":"10.4049\/jimmunol.1101040"},{"issue":"14","key":"1715_CR11","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"X-L Fan","year":"2020","unstructured":"Fan X-L, Zhang Y, Li X, Fu Q-L (2020) Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci 77(14):2771\u201394. https:\/\/doi.org\/10.1007\/s00018-020-03454-6","journal-title":"Cell Mol Life Sci"},{"key":"1715_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biology10030172","volume":"10","author":"S Fuloria","year":"2021","unstructured":"Fuloria S, Subramaniyan V, Dahiya R, Dahiya S, Sudhakar K, Kumari U et al (2021) Mesenchymal stem cell-derived extracellular vesicles: regenerative potential and challenges. Biology 10:172","journal-title":"Biology"},{"issue":"4","key":"1715_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-023-02552-6","volume":"145","author":"A Geladaris","year":"2023","unstructured":"Geladaris A, H\u00e4usser-Kinzel S, Pretzsch R, Nissimov N, Lehmann-Horn K, H\u00e4usler D et al (2023) IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity. Acta Neuropathol 145(4):461\u201377","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1715_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ana.21076","volume":"61","author":"E Gerdoni","year":"2007","unstructured":"Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E et al (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61(3):219\u201327","journal-title":"Ann Neurol"},{"key":"1715_CR88","doi-asserted-by":"publisher","unstructured":"Glenn JD, Smith MD, Calabresi PA, Whartenby KA (2014) Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis. Stem cells 32(10):2744-2755. https:\/\/doi.org\/10.1002\/stem.1755","DOI":"10.1002\/stem.1755"},{"key":"1715_CR81","doi-asserted-by":"publisher","unstructured":"Glenn JD, Smith MD, Kirby LA, Baxi EG, Whartenby KA (2015) Disparate effects of mesenchymal stem cells in experimental autoimmune encephalomyelitis and cuprizone-induced demyelination. PLoS One 10(9):e0139008. https:\/\/doi.org\/10.1371\/journal.pone.0139008","DOI":"10.1371\/journal.pone.0139008"},{"issue":"1","key":"1715_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-024-06103-5","volume":"24","author":"B Golabi","year":"2024","unstructured":"Golabi B, Razmaray H, Seyedi-Sahebari S, Bandehagh H, Hakimzadeh Z, Khosroshahi A et al (2024) Sleep and cognitive outcomes in multiple sclerosis; a systematic review. BMC Psychiatry 24(1):638","journal-title":"BMC Psychiatry"},{"issue":"11","key":"1715_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/NEN.0b013e3181f97392","volume":"69","author":"D Gordon","year":"2010","unstructured":"Gordon D, Pavlovska G, Uney JB, Wraith DC, Scolding NJ (2010) Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol 69(11):1087\u201395","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1715_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.expneurol.2011.02.021","volume":"230","author":"N Grigoriadis","year":"2011","unstructured":"Grigoriadis N, Lourbopoulos A, Lagoudaki R, Frischer J-M, Polyzoidou E, Touloumi O et al (2011) Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. Exp Neurol 230(1):78\u201389","journal-title":"Exp Neurol"},{"key":"1715_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228662","author":"A Gugliandolo","year":"2020","unstructured":"Gugliandolo A, Bramanti P, Mazzon E (2020) Mesenchymal stem cells in multiple sclerosis: recent evidence from pre-clinical to clinical studies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228662","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1715_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000351450","volume":"20","author":"Y Guo","year":"2013","unstructured":"Guo Y, Chan K-H, Lai W-H, Siu C-W, Kwan S-C, Tse H-F et al (2013) Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis. Neuroimmunomodulation 20(5):294\u2013303","journal-title":"Neuroimmunomodulation"},{"issue":"12","key":"1715_CR20","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1007\/s11033-023-08843-1","volume":"50","author":"D Haghmorad","year":"2023","unstructured":"Haghmorad D, Khaleghian A, Eslami M, Sadeghnejad A, Tarahomi M, Yousefi B (2023) Bone marrow mesenchymal stem cells to ameliorate experimental autoimmune encephalomyelitis via modifying expression patterns of miRNAs. Mol Biol Rep 50(12):9971\u20139984","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1715_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000437429","volume":"23","author":"F Hao","year":"2016","unstructured":"Hao F, Li A, Yu H, Liu M, Wang Y, Liu J et al (2016) Enhanced Neuroprotective Effects of Combination Therapy with Bone Marrow-Derived Mesenchymal Stem Cells and Ginkgo biloba Extract (EGb761) in a Rat Model of Experimental Autoimmune Encephalomyelitis. Neuroimmunomodulation 23(1):41\u201357","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"1715_CR23","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1007\/s11033-019-05048-3","volume":"46","author":"R Heidari Barchi Nezhad","year":"2019","unstructured":"Heidari Barchi Nezhad R, Asadi F, Abtahi Froushani SM, Hassanshahi G, Kaeidi A, Khanamani Falahati-Pour S et al (2019) The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis. Mol Biol Rep 46(6):6135\u20136146","journal-title":"Mol Biol Rep"},{"issue":"9","key":"1715_CR24","first-page":"936","volume":"21","author":"R Heidari Barchi Nezhad","year":"2018","unstructured":"Heidari Barchi Nezhad R, Asadi F, Mirzaei MR, Abtahi Froushani SM (2018) Comparison of the effects of 17\u03b2- estradiol treated and untreated mesenchymal stem cells on ameliorating animal model of multiple sclerosis. Iran J Basic Med Sci 21(9):936\u2013942","journal-title":"Iran J Basic Med Sci"},{"key":"1715_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711362","volume":"12","author":"J He","year":"2021","unstructured":"He J, Huang Y, Liu J, Lan Z, Tang X, Hu Z (2021) The efficacy of mesenchymal stem cell therapies in rodent models of multiple sclerosis: an updated systematic review and meta-analysis. Front Immunol 12:711362","journal-title":"Front Immunol"},{"issue":"11","key":"1715_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"18","key":"1715_CR26","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.3390\/ijms26188817","volume":"26","author":"HL Hohm","year":"2025","unstructured":"Hohm HL, Schuster R, Buciu VB, Serban D-M, Ciurescu S, Cornea A et al (2025) Glial cytokine and metabolic networks in progressive multiple sclerosis: from pathophysiology to biomarkers and therapeutic strategies. Int J Mol Sci 26(18):8817","journal-title":"Int J Mol Sci"},{"key":"1715_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"1715_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/scrt228","volume":"4","author":"Y Hou","year":"2013","unstructured":"Hou Y, Ryu CH, Park KY, Kim SM, Jeong CH, Jeun S-S (2013) Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice. Stem Cell Res Ther 4(4):77","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"1715_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.304","volume":"4","author":"J Jaramillo-Merch\u00e1n","year":"2013","unstructured":"Jaramillo-Merch\u00e1n J, Jones J, Ivorra JL, Pastor D, Viso-Le\u00f3n MC, Armeng\u00f3l JA et al (2013) Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model. Cell Death Dis 4(8):e779","journal-title":"Cell Death Dis"},{"key":"1715_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2021.03.003","volume":"233","author":"I Kassis","year":"2021","unstructured":"Kassis I, Ben-Zwi M, Petrou P, Halimi M, Karussis D (2021) Synergistic neuroprotective effects of Fingolimod and mesenchymal stem cells (MSC) in experimental autoimmune encephalomyelitis. Immunol Lett 233:11\u201319","journal-title":"Immunol Lett"},{"issue":"6","key":"1715_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archneur.65.6.753","volume":"65","author":"I Kassis","year":"2008","unstructured":"Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S et al (2008) Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65(6):753\u201361","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"1715_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.imlet.2013.06.002","volume":"154","author":"I Kassis","year":"2013","unstructured":"Kassis I, Petrou P, Halimi M, Karussis D (2013) Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors. Immunol Lett 154(1\u20132):70\u201376","journal-title":"Immunol Lett"},{"issue":"10","key":"1715_CR33","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173\u20135","journal-title":"Nat Med"},{"issue":"4","key":"1715_CR34","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0002-9440(10)63232-4","volume":"164","author":"M Kerschensteiner","year":"2004","unstructured":"Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC et al (2004) Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 164(4):1455\u201369","journal-title":"Am J Pathol"},{"issue":"1","key":"1715_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections. J Epidemiol Glob Health 15(1):21","journal-title":"J Epidemiol Glob Health"},{"issue":"2","key":"1715_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08820139.2017.1391841","volume":"47","author":"S Khezri","year":"2018","unstructured":"Khezri S, Abtahi Froushani SM, Shahmoradi M (2018) Nicotine augments the beneficial effects of mesenchymal stem cell-based therapy in rat model of multiple sclerosis. Immunol Invest 47(2):113\u2013124","journal-title":"Immunol Invest"},{"key":"1715_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jneuroim.2017.11.010","volume":"314","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, Lim JY, Park SA, Park SI, Kim WS, Ryu CH et al (2018) Effective combination of methylprednisolone and interferon \u03b2-secreting mesenchymal stem cells in a model of multiple sclerosis. J Neuroimmunol 314:81\u20138","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1715_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s13770-017-0101-y","volume":"15","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, Ryu CH, Kim SM, Lim JY, Kim WS, Jeun S-S (2018) Combined treatment with methylprednisolone and human bone marrow-derived mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis. Tissue Eng Regen Med 15(2):183\u2013194","journal-title":"Tissue Eng Regen Med"},{"key":"1715_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/140170","volume":"2015","author":"M Kurte","year":"2015","unstructured":"Kurte M, Bravo-Alegr\u00eda J, Torres A, Carrasco V, Ib\u00e1\u00f1ez C, Vega-Letter AM et al (2015) Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis. Stem Cells Int 2015:140170","journal-title":"Stem Cells Int"},{"issue":"5","key":"1715_CR40","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/j.1471-4159.2009.06268.x","volume":"110","author":"C Lanza","year":"2009","unstructured":"Lanza C, Morando S, Voci A, Canesi L, Principato MC, Serpero LD et al (2009) Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J Neurochem 110(5):1674\u201384","journal-title":"J Neurochem"},{"key":"1715_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biomaterials.2015.11.005","volume":"77","author":"W Liao","year":"2016","unstructured":"Liao W, Pham V, Liu L, Riazifar M, Pone EJ, Zhang SX et al (2016) Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Biomaterials 77:87\u201397","journal-title":"Biomaterials"},{"issue":"9","key":"1715_CR43","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1007\/s12035-020-01998-z","volume":"57","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ma Y, Du B, Wang Y, Yang G-Y, Bi X (2020) Mesenchymal stem cells attenuated blood-brain barrier disruption via downregulation of aquaporin-4 expression in EAE mice. Mol Neurobiol 57(9):3891\u20133901","journal-title":"Mol Neurobiol"},{"key":"1715_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","volume":"67","author":"Z Li","year":"2019","unstructured":"Li Z, Liu F, He X, Yang X, Shan F, Feng J (2019) Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int Immunopharmacol 67:268\u2013280","journal-title":"Int Immunopharmacol"},{"key":"1715_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-444-52001-2.00004-2","volume":"122","author":"C Lubetzki","year":"2014","unstructured":"Lubetzki C, Stankoff B (2014) Demyelination in multiple sclerosis. Handb Clin Neurol 122:89\u201399","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"1715_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford P, Kurte M, Bravo-Alegr\u00eda J, Contreras R, Nova-Lamperti E, Tejedor G et al (2013) Mesenchymal stem cells generate a CD4\u2009+\u2009CD25+Foxp3\u2009+\u2009regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4(3):65","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"1715_CR46","doi-asserted-by":"publisher","first-page":"e21936","DOI":"10.1002\/jbt.21936","volume":"31","author":"MM Mahfouz","year":"2017","unstructured":"Mahfouz MM, Abdelsalam RM, Masoud MA, Mansour HA, Ahmed-Farid OA, Kenawy SA (2017) The neuroprotective effect of mesenchymal stem cells on an experimentally induced model for multiple sclerosis in mice. J Biochem Mol Toxicol 31(9):e21936","journal-title":"J Biochem Mol Toxicol"},{"issue":"1\u20132","key":"1715_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jneuroim.2009.02.017","volume":"210","author":"TK Makar","year":"2009","unstructured":"Makar TK, Bever CT, Singh IS, Royal W, Sahu SN, Sura TP et al (2009) Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J Neuroimmunol 210(1\u20132):40\u201351","journal-title":"J Neuroimmunol"},{"key":"1715_CR82","doi-asserted-by":"publisher","unstructured":"Matysiak M, Orlowski W, Fortak-Michalska M, Jurewicz A, Selmaj K (2011) Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J Neuroimmunol 233(1-2):106-111. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.12.004","DOI":"10.1016\/j.jneuroim.2010.12.004"},{"issue":"30","key":"1715_CR48","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.12998\/wjcc.v12.i30.6361","volume":"12","author":"R Medina","year":"2024","unstructured":"Medina R, Derias A-M, Lakdawala M, Speakman S, Lucke-Wold B (2024) Overview of emerging therapies for demyelinating diseases. World J Clin Cases 12(30):6361\u20136373","journal-title":"World J Clin Cases"},{"issue":"10","key":"1715_CR49","first-page":"12041","volume":"8","author":"NK Mitra","year":"2015","unstructured":"Mitra NK, Bindal U, Eng Hwa W, Chua CLL, Tan CY (2015) Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells. Int J Clin Exp Pathol 8(10):12041\u201352","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"1715_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.15283\/ijsc17052","volume":"11","author":"F Nasri","year":"2018","unstructured":"Nasri F, Mohtasebi M-S, Hashemi E, Zarrabi M, Gholijani N, Sarvestani EK (2018) Therapeutic efficacy of mesenchymal stem cells and mesenchymal stem cells-derived neural progenitors in experimental autoimmune encephalomyelitis. Int J Stem Cells 11(1):68\u201377","journal-title":"Int J Stem Cells"},{"issue":"5","key":"1715_CR51","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.4049\/jimmunol.1101040","volume":"188","author":"DY Oh","year":"2012","unstructured":"Oh DY, Cui P, Hosseini H, Mosse J, Toh B-H, Chan J (2012) Potently immunosuppressive 5-fluorouracil-resistant mesenchymal stromal cells completely remit an experimental autoimmune disease. J Immunol 188(5):2207\u20132217","journal-title":"J Immunol"},{"issue":"8","key":"1715_CR52","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3727\/096368912X657620","volume":"22","author":"NL Payne","year":"2013","unstructured":"Payne NL, Sun G, McDonald C, Layton D, Moussa L, Emerson-Webber A et al (2013) Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant 22(8):1409\u201325","journal-title":"Cell Transplant"},{"issue":"1","key":"1715_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12974-023-02785-y","volume":"20","author":"V Pegoretti","year":"2023","unstructured":"Pegoretti V, Bauer J, Fischer R, Paro I, Douwenga W, Kontermann RE et al (2023) Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS. J Neuroinflammation 20(1):106","journal-title":"J Neuroinflammation"},{"issue":"6","key":"1715_CR54","doi-asserted-by":"publisher","DOI":"10.4142\/jvs.2021.22.e74","volume":"22","author":"M Purwaningrum","year":"2021","unstructured":"Purwaningrum M, Jamilah NS, Purbantoro SD, Sawangmake C, Nantavisai S (2021) Comparative characteristic study from bone marrow-derived mesenchymal stem cells. J Vet Sci 22(6):e74","journal-title":"J Vet Sci"},{"issue":"10","key":"1715_CR55","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","volume":"182","author":"M Rafei","year":"2009","unstructured":"Rafei M, Campeau PA, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E et al (2009) Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T Cells in a CC chemokine lisgand 2-dependent manner. J Immunol 182(10):5994\u20136002","journal-title":"J Immunol"},{"issue":"2","key":"1715_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple Sclerosis. N Engl J Med 378(2):169\u2013180","journal-title":"N Engl J Med"},{"key":"1715_CR85","doi-asserted-by":"publisher","unstructured":"Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lasser C, Segaliny AI, Zhao W (2019) Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS nano 13(6):6670-6688. https:\/\/doi.org\/10.1021\/acsnano.9b01004","DOI":"10.1021\/acsnano.9b01004"},{"key":"1715_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0091-1","volume":"15","author":"C R\u00f6ver","year":"2015","unstructured":"R\u00f6ver C, Knapp G, Friede T (2015) Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol 15:99","journal-title":"BMC Med Res Methodol"},{"key":"1715_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/696738","volume":"2013","author":"CH Ryu","year":"2013","unstructured":"Ryu CH, Park KY, Hou Y, Jeong CH, Kim SM, Jeun S-S (2013) Gene therapy of multiple sclerosis using interferon \u03b2-secreting human bone marrow mesenchymal stem cells. Biomed Res Int 2013:696738","journal-title":"Biomed Res Int"},{"issue":"11","key":"1715_CR59","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/apm.13456","volume":"132","author":"A Sadeghnejad","year":"2024","unstructured":"Sadeghnejad A, Pazoki A, Yazdanpanah E, Esmaeili S-A, Yousefi B, Sadighi-Moghaddam B et al (2024) Exploring the role of mesenchymal stem cells in modulating immune responses via Treg and Th2 cell activation: insights from mouse model of multiple sclerosis. APMIS 132(11):888\u201399","journal-title":"APMIS"},{"key":"1715_CR60","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.expneurol.2017.06.013","volume":"295","author":"A Sargent","year":"2017","unstructured":"Sargent A, Bai L, Shano G, Karl M, Garrison E, Ranasinghe L et al (2017) CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells. Exp Neurol 295:222\u201332","journal-title":"Exp Neurol"},{"issue":"8","key":"1715_CR61","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3727\/096368908786576480","volume":"17","author":"R Sch\u00e4fer","year":"2008","unstructured":"Sch\u00e4fer R, Ayturan M, Bantleon R, Kehlbach R, Siegel G, Pintaske J et al (2008) The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution. Cell Transplant 17(8):923\u201341","journal-title":"Cell Transplant"},{"issue":"1","key":"1715_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/scrt391","volume":"5","author":"JA Semon","year":"2014","unstructured":"Semon JA, Maness C, Zhang X, Sharkey SA, Beuttler MM, Shah FS et al (2014) Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis. Stem Cell Res Ther 5(1):2","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"1715_CR63","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3390\/biomedicines12092113","volume":"12","author":"S Shah","year":"2024","unstructured":"Shah S, Mansour HM, Aguilar TM, Lucke-Wold B (2024) Mesenchymal stem cell-derived exosomes as a neuroregeneration treatment for Alzheimer\u2019s disease. Biomedicines 12(9):2113","journal-title":"Biomedicines"},{"key":"1715_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2019.02.032","volume":"299","author":"FH Shamili","year":"2019","unstructured":"Shamili FH, Alibolandi M, Rafatpanah H, Abnous K, Mahmoudi M, Kalantari M et al (2019) Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release 299:149\u201364","journal-title":"J Control Release"},{"key":"1715_CR86","doi-asserted-by":"publisher","unstructured":"Shamili FH, Alibolandi M, Rafatpanah H, Abnous K, Mahmoudi M, Kalantari M, Ramezani M (2019) Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release 299:149-164. https:\/\/doi.org\/10.1016\/j.jconrel.2019.02.032","DOI":"10.1016\/j.jconrel.2019.02.032"},{"issue":"4","key":"1715_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2217\/rme-2016-0109","volume":"12","author":"SP Singh","year":"2017","unstructured":"Singh SP, Jadhav SH, Chaturvedi CP, Nityanand S (2017) Therapeutic efficacy of multipotent adult progenitor cells versus mesenchymal stem cells in experimental autoimmune encephalomyelitis. Regen Med 12(4):377\u2013396","journal-title":"Regen Med"},{"issue":"5","key":"1715_CR66","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/glia.23958","volume":"69","author":"T Vigo","year":"2021","unstructured":"Vigo T, Voulgari-Kokota A, Errede M, Girolamo F, Ortolan J, Mariani MC et al (2021) Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes. Glia 69(5):1204\u201315","journal-title":"Glia"},{"key":"1715_CR67","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijdevneu.2016.01.005","volume":"49","author":"D Wang","year":"2016","unstructured":"Wang D, Li S-P, Fu J-S, Bai L, Guo L (2016) Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Int J Dev Neurosci Off J Int Soc Dev Neurosci 49:60\u201366","journal-title":"Int J Dev Neurosci Off J Int Soc Dev Neurosci"},{"key":"1715_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114374","volume":"363","author":"J Wang","year":"2023","unstructured":"Wang J, Sun H, Guo R, Guo J, Tian X, Wang J et al (2023) Exosomal miR-23b-3p from bone mesenchymal stem cells alleviates experimental autoimmune encephalomyelitis by inhibiting microglial pyroptosis. Exp Neurol 363:114374","journal-title":"Exp Neurol"},{"key":"1715_CR80","doi-asserted-by":"publisher","unstructured":"Wang J, Wang, G, Sun B, Li H, Mu L, Wang Q, Kostulas N (2008) Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment. J Autoimmun 30(4):222-229. https:\/\/doi.org\/10.1016\/j.jaut.2007.10.001","DOI":"10.1016\/j.jaut.2007.10.001"},{"key":"1715_CR69","doi-asserted-by":"publisher","first-page":"113853","DOI":"10.1016\/j.intimp.2024.113853","volume":"146","author":"J Wu","year":"2025","unstructured":"Wu J, Li A, Shi Y, Wang Y, Luo J, Zhuang W et al (2025) Intranasal delivery of mesenchymal stem cell-derived exosomes ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol 146:113853","journal-title":"Int Immunopharmacol"},{"key":"1715_CR87","doi-asserted-by":"publisher","unstructured":"Xin Y, Gao J, Hu R, Li H, Li Q, Han F, Su M (2020) Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation. Immunol Lett 225, 66-73. https:\/\/doi.org\/10.1016\/j.imlet.2020.05.005","DOI":"10.1016\/j.imlet.2020.05.005"},{"key":"1715_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972247","volume":"13","author":"C Xun","year":"2022","unstructured":"Xun C, Deng H, Zhao J, Ge L, Hu Z (2022) Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: a meta-analysis. Front Immunol 13:972247","journal-title":"Front Immunol"},{"key":"1715_CR71","doi-asserted-by":"crossref","unstructured":"Yari H, Mikhailova MV, Mardasi M, Jafarzadehgharehziaaddin M, Shahrokh S, Thangavelu L et al (2022) Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach. Stem Cell Res Ther 13(1). Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecordid=L2018719595from=export","DOI":"10.1186\/s13287-022-03122-5"},{"issue":"4","key":"1715_CR72","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12031-016-0819-3","volume":"60","author":"J-W Yu","year":"2016","unstructured":"Yu J-W, Li Y-H, Song G-B, Yu J-Z, Liu C-Y, Liu J-C et al (2016) Synergistic and superimposed effect of bone marrow-derived mesenchymal stem cells combined with Fasudil in experimental autoimmune encephalomyelitis. J Mol Neurosci 60(4):486\u201397","journal-title":"J Mol Neurosci"},{"issue":"5","key":"1715_CR73","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106(5):1755\u201361","journal-title":"Blood"},{"issue":"1\u20132","key":"1715_CR74","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jns.2008.12.033","volume":"279","author":"J Zhang","year":"2009","unstructured":"Zhang J, Brodie C, Li Y, Zheng X, Roberts C, Lu M et al (2009) Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis. J Neurol Sci 279(1\u20132):30\u20138","journal-title":"J Neurol Sci"},{"key":"1715_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113895","volume":"347","author":"J Zhang","year":"2022","unstructured":"Zhang J, Buller BA, Zhang ZG, Zhang Y, Lu M, Rosene DL et al (2022) Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol 347:113895","journal-title":"Exp Neurol"},{"issue":"1","key":"1715_CR76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.expneurol.2005.03.018","volume":"195","author":"J Zhang","year":"2005","unstructured":"Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB et al (2005) Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195(1):16\u201326","journal-title":"Exp Neurol"},{"issue":"3","key":"1715_CR77","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jnr.20962","volume":"84","author":"J Zhang","year":"2006","unstructured":"Zhang J, Li Y, Lu M, Cui Y, Chen J, Noffsinger L et al (2006) Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 84(3):587\u201395","journal-title":"J Neurosci Res"},{"issue":"11","key":"1715_CR78","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.4314\/tjpr.v17i11.16","volume":"17","author":"JM Zhang","year":"2018","unstructured":"Zhang JM, Wang H, Fan YY, Yang FH (2018) Effect of mesenchymal stem cell transplantation on behavior and structural changes in myelin in experimental rat autoimmune encephalomyelitis. Trop J Pharm Res 17(11):2219\u20132225","journal-title":"Trop J Pharm Res"},{"key":"1715_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8536785","volume":"2019","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhang X, Xue H, Liu L, Zhu J, Jin T (2019) Autologous mesenchymal stem cell transplantation in multiple sclerosis: a meta-analysis. Stem Cells Int 2019:8536785","journal-title":"Stem Cells Int"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01715-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01715-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01715-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:02:41Z","timestamp":1779933761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01715-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1715"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01715-9","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"96"}}